Tag: GlobeNewswire

Existing customer expands AI vehicle recognition deployment at a nonprofit institution known for integrated patient care, research and education

SALT LAKE CITY, Nov. 03, 2026 (GLOBE NEWSWIRE) — OMNIQ CORP. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of AI-based computer vision technology, today announced a new contract to deploy its license plate recognition (LPR) technology across 29 additional lanes at a major U.S. academic medical center.

The contract builds on the customer’s existing deployment and extends OMNIQ’s vehicle recognition technology to additional parking lanes. The system identifies vehicles at entry and exit points, providing data to support parking management and daily operations.

“Healthcare campuses need parking technology that works reliably every day,” said Shai Lustgarten, chairman and CEO of OMNIQ. “This customer’s decision to add 29 lanes reflects the trust we’ve built through our existing deployment. For OMNIQ, it demonstrates how established customer relationships can translate into additional business.”

The award supports OMNIQ’s strategy of expanding its AI-based solutions within established customer accounts, building on existing installations to serve additional operational needs.

ABOUT OMNIQ

OMNIQ CORP. uses patented and proprietary artificial intelligence to deliver machine vision image processing solutions, including data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic and parking management, and access control applications.

Our solutions help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders and other environments.

Our principal solutions include hardware, software, communications, automated management services, technical services and support. Our experienced team helps customers simplify integration and deploy practical solutions across complex operating environments.

Privacy and Data Security Commitment

OMNIQ solutions are built to meet the privacy and data protection requirements of the agencies that use them. License plate data is processed and stored in a private network, and access is limited to authorized personnel at the contracting agency. Data is retained and purged according to the agency’s policy and applicable state law. OMNIQ does not sell plate data or share it with third parties for commercial purposes.

For more information about OMNIQ Corp. and its innovative solutions, please visit www.omniq.com.

INFORMATION ABOUT FORWARD LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate,” “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

Examples of forward-looking statements include, among others, statements made in this press release regarding the expected timing of the Pennsylvania deployments, anticipated citation processing fee revenue, and additional municipal agreements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at SEC.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.

Contact

Company

IR@OMNIQ.COM

HAYDEN IR:
Brett Maas
(646) 536-7331
brett@haydenir.com

James Carbonara
(646)-755-7412
james@haydenir.com

Existing customer expands AI vehicle recognition deployment at a nonprofit institution known for integrated patient care, research and education

SALT LAKE CITY, Nov. 03, 2026 (GLOBE NEWSWIRE) — OMNIQ CORP. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of AI-based computer vision technology, today announced a new contract to deploy its license plate recognition (LPR) technology across 29 additional lanes at a major U.S. academic medical center.

The contract builds on the customer’s existing deployment and extends OMNIQ’s vehicle recognition technology to additional parking lanes. The system identifies vehicles at entry and exit points, providing data to support parking management and daily operations.

“Healthcare campuses need parking technology that works reliably every day,” said Shai Lustgarten, chairman and CEO of OMNIQ. “This customer’s decision to add 29 lanes reflects the trust we’ve built through our existing deployment. For OMNIQ, it demonstrates how established customer relationships can translate into additional business.”

The award supports OMNIQ’s strategy of expanding its AI-based solutions within established customer accounts, building on existing installations to serve additional operational needs.

ABOUT OMNIQ

OMNIQ CORP. uses patented and proprietary artificial intelligence to deliver machine vision image processing solutions, including data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic and parking management, and access control applications.

Our solutions help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders and other environments.

Our principal solutions include hardware, software, communications, automated management services, technical services and support. Our experienced team helps customers simplify integration and deploy practical solutions across complex operating environments.

Privacy and Data Security Commitment

OMNIQ solutions are built to meet the privacy and data protection requirements of the agencies that use them. License plate data is processed and stored in a private network, and access is limited to authorized personnel at the contracting agency. Data is retained and purged according to the agency’s policy and applicable state law. OMNIQ does not sell plate data or share it with third parties for commercial purposes.

For more information about OMNIQ Corp. and its innovative solutions, please visit www.omniq.com.

INFORMATION ABOUT FORWARD LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate,” “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

Examples of forward-looking statements include, among others, statements made in this press release regarding the expected timing of the Pennsylvania deployments, anticipated citation processing fee revenue, and additional municipal agreements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at SEC.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.

Contact

Company

IR@OMNIQ.COM

HAYDEN IR:
Brett Maas
(646) 536-7331
brett@haydenir.com

James Carbonara
(646)-755-7412
james@haydenir.com

Existing customer expands AI vehicle recognition deployment at a nonprofit institution known for integrated patient care, research and education

SALT LAKE CITY, Nov. 03, 2026 (GLOBE NEWSWIRE) — OMNIQ CORP. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of AI-based computer vision technology, today announced a new contract to deploy its license plate recognition (LPR) technology across 29 additional lanes at a major U.S. academic medical center.

The contract builds on the customer’s existing deployment and extends OMNIQ’s vehicle recognition technology to additional parking lanes. The system identifies vehicles at entry and exit points, providing data to support parking management and daily operations.

“Healthcare campuses need parking technology that works reliably every day,” said Shai Lustgarten, chairman and CEO of OMNIQ. “This customer’s decision to add 29 lanes reflects the trust we’ve built through our existing deployment. For OMNIQ, it demonstrates how established customer relationships can translate into additional business.”

The award supports OMNIQ’s strategy of expanding its AI-based solutions within established customer accounts, building on existing installations to serve additional operational needs.

ABOUT OMNIQ

OMNIQ CORP. uses patented and proprietary artificial intelligence to deliver machine vision image processing solutions, including data collection, real-time surveillance and monitoring for supply chain management, homeland security, public safety, traffic and parking management, and access control applications.

Our solutions help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders and other environments.

Our principal solutions include hardware, software, communications, automated management services, technical services and support. Our experienced team helps customers simplify integration and deploy practical solutions across complex operating environments.

Privacy and Data Security Commitment

OMNIQ solutions are built to meet the privacy and data protection requirements of the agencies that use them. License plate data is processed and stored in a private network, and access is limited to authorized personnel at the contracting agency. Data is retained and purged according to the agency’s policy and applicable state law. OMNIQ does not sell plate data or share it with third parties for commercial purposes.

For more information about OMNIQ Corp. and its innovative solutions, please visit www.omniq.com.

INFORMATION ABOUT FORWARD LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate,” “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements.

Examples of forward-looking statements include, among others, statements made in this press release regarding the expected timing of the Pennsylvania deployments, anticipated citation processing fee revenue, and additional municipal agreements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at SEC.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.

Contact

Company

IR@OMNIQ.COM

HAYDEN IR:
Brett Maas
(646) 536-7331
brett@haydenir.com

James Carbonara
(646)-755-7412
james@haydenir.com

DELAWARE, Ohio, Nov. 03, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.62 per share on its Class A Common Stock, and $0.92 per share on its Class B Common Stock.

Dividends are payable on January 1, 2027, to stockholders of record at the close of business on December 17, 2026.

About Greif

Founded in 1877, Greif is a global leader in performance packaging located in 35 countries. The company delivers trusted, innovative, and tailored solutions that support some of the world’s most demanding and fastest-growing industries. With a commitment to legendary customer service, operational excellence, and global sustainability, Greif packages life’s essentials – and creates lasting value for its colleagues, customers, and other stakeholders. Learn more about the company’s Customized Polymer, Sustainable Fiber, Durable Metal, and Innovative Closure Solutions at www.greif.com and follow Greif on Instagram and LinkedIn.

Contact:

Bill D’Onofrio
614-499-7233
bill.donofrio@greif.com

DELAWARE, Ohio, Nov. 03, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.62 per share on its Class A Common Stock, and $0.92 per share on its Class B Common Stock.

Dividends are payable on January 1, 2027, to stockholders of record at the close of business on December 17, 2026.

About Greif

Founded in 1877, Greif is a global leader in performance packaging located in 35 countries. The company delivers trusted, innovative, and tailored solutions that support some of the world’s most demanding and fastest-growing industries. With a commitment to legendary customer service, operational excellence, and global sustainability, Greif packages life’s essentials – and creates lasting value for its colleagues, customers, and other stakeholders. Learn more about the company’s Customized Polymer, Sustainable Fiber, Durable Metal, and Innovative Closure Solutions at www.greif.com and follow Greif on Instagram and LinkedIn.

Contact:

Bill D’Onofrio
614-499-7233
bill.donofrio@greif.com

DELAWARE, Ohio, Nov. 03, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.62 per share on its Class A Common Stock, and $0.92 per share on its Class B Common Stock.

Dividends are payable on January 1, 2027, to stockholders of record at the close of business on December 17, 2026.

About Greif

Founded in 1877, Greif is a global leader in performance packaging located in 35 countries. The company delivers trusted, innovative, and tailored solutions that support some of the world’s most demanding and fastest-growing industries. With a commitment to legendary customer service, operational excellence, and global sustainability, Greif packages life’s essentials – and creates lasting value for its colleagues, customers, and other stakeholders. Learn more about the company’s Customized Polymer, Sustainable Fiber, Durable Metal, and Innovative Closure Solutions at www.greif.com and follow Greif on Instagram and LinkedIn.

Contact:

Bill D’Onofrio
614-499-7233
bill.donofrio@greif.com

Expansion option exercised within weeks as customer increases data volume to support its derivative data offering

MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it has received a high six-figure add-on order under the multiyear agreement announced on September 30, 2026. The order exercises the expansion option included in that agreement, increasing data volume by 150% with the commercially scaled AI-enabled precision medicine customer.

The September 30 agreement established a multiyear license for de-identified, multimodal, longitudinal clinical Real-World Data. The customer is using the data to train AI-enabled clinical and diagnostic models and to build a licensable derivative dataset for sale into its own channel. The new add-on order, received within weeks of the original announcement, reflects the customer’s determination that additional data volume is required to support its derivative data offering.

“Our customers come back for repeat data add-on orders for three reasons: the speed with which we deliver, the quality of our full-fidelity longitudinal data, and the depth of our data, which comes from first-party sources: our healthcare provider partners, not intermediaries or secondary markets,” said Aaron Green, President & CEO of OneMedNet. “We’re seeing that play out here. Within weeks of signing on September 30, our customer exercised its expansion option to support its growing derivative data offering, and we expect the relationship to grow as its solution does.”

OneMedNet sources its data from a live network of more than 2,300 healthcare partner sites, applying de-identification at the source at the scale and standards required to train evolving AI foundation models and to meet life sciences commercial data needs.

Order highlights

• High six-figure add-on order, exercising the expansion option under the multiyear agreement announced September 30, 2026.
• Additional data volume requested within weeks of the original announcement to support the customer’s derivative data offering.
• Structure retains the potential for recurring sublicensing revenue to OneMedNet on future end-customer licenses of the partner-sold derivative dataset.
• OneMedNet retains source-data rights. End customers of the derivative may not relicense or resell the underlying OneMedNet data.

About OneMedNet Corporation

OneMedNet Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Learn more at www.onemednet.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to statements regarding the benefits and capabilities of our products and the customer agreement, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:

Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

Expansion option exercised within weeks as customer increases data volume to support its derivative data offering

MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it has received a high six-figure add-on order under the multiyear agreement announced on September 30, 2026. The order exercises the expansion option included in that agreement, increasing data volume by 150% with the commercially scaled AI-enabled precision medicine customer.

The September 30 agreement established a multiyear license for de-identified, multimodal, longitudinal clinical Real-World Data. The customer is using the data to train AI-enabled clinical and diagnostic models and to build a licensable derivative dataset for sale into its own channel. The new add-on order, received within weeks of the original announcement, reflects the customer’s determination that additional data volume is required to support its derivative data offering.

“Our customers come back for repeat data add-on orders for three reasons: the speed with which we deliver, the quality of our full-fidelity longitudinal data, and the depth of our data, which comes from first-party sources: our healthcare provider partners, not intermediaries or secondary markets,” said Aaron Green, President & CEO of OneMedNet. “We’re seeing that play out here. Within weeks of signing on September 30, our customer exercised its expansion option to support its growing derivative data offering, and we expect the relationship to grow as its solution does.”

OneMedNet sources its data from a live network of more than 2,300 healthcare partner sites, applying de-identification at the source at the scale and standards required to train evolving AI foundation models and to meet life sciences commercial data needs.

Order highlights

• High six-figure add-on order, exercising the expansion option under the multiyear agreement announced September 30, 2026.
• Additional data volume requested within weeks of the original announcement to support the customer’s derivative data offering.
• Structure retains the potential for recurring sublicensing revenue to OneMedNet on future end-customer licenses of the partner-sold derivative dataset.
• OneMedNet retains source-data rights. End customers of the derivative may not relicense or resell the underlying OneMedNet data.

About OneMedNet Corporation

OneMedNet Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Learn more at www.onemednet.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to statements regarding the benefits and capabilities of our products and the customer agreement, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:

Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

Expansion option exercised within weeks as customer increases data volume to support its derivative data offering

MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it has received a high six-figure add-on order under the multiyear agreement announced on September 30, 2026. The order exercises the expansion option included in that agreement, increasing data volume by 150% with the commercially scaled AI-enabled precision medicine customer.

The September 30 agreement established a multiyear license for de-identified, multimodal, longitudinal clinical Real-World Data. The customer is using the data to train AI-enabled clinical and diagnostic models and to build a licensable derivative dataset for sale into its own channel. The new add-on order, received within weeks of the original announcement, reflects the customer’s determination that additional data volume is required to support its derivative data offering.

“Our customers come back for repeat data add-on orders for three reasons: the speed with which we deliver, the quality of our full-fidelity longitudinal data, and the depth of our data, which comes from first-party sources: our healthcare provider partners, not intermediaries or secondary markets,” said Aaron Green, President & CEO of OneMedNet. “We’re seeing that play out here. Within weeks of signing on September 30, our customer exercised its expansion option to support its growing derivative data offering, and we expect the relationship to grow as its solution does.”

OneMedNet sources its data from a live network of more than 2,300 healthcare partner sites, applying de-identification at the source at the scale and standards required to train evolving AI foundation models and to meet life sciences commercial data needs.

Order highlights

• High six-figure add-on order, exercising the expansion option under the multiyear agreement announced September 30, 2026.
• Additional data volume requested within weeks of the original announcement to support the customer’s derivative data offering.
• Structure retains the potential for recurring sublicensing revenue to OneMedNet on future end-customer licenses of the partner-sold derivative dataset.
• OneMedNet retains source-data rights. End customers of the derivative may not relicense or resell the underlying OneMedNet data.

About OneMedNet Corporation

OneMedNet Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Learn more at www.onemednet.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to statements regarding the benefits and capabilities of our products and the customer agreement, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:

Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a global data and AI company, announced that it has been recognized as Leader and Star Performer in the Everest Group Customer Experience Management (CXM) PEAK Matrix Assessment – Americas 2026 report.

The Everest Group report evaluated 63 leading customer experience management providers on their ability to meet enterprise needs and deliver scalable, secure and high-impact CXM solutions through AI-enabled operations, domain expertise, operational resilience, and proven execution capabilities. EXL was recognized as a Leader and Star Performer for its deep domain experience, speed and flexibility of solutions, and strength in customer experience transformation. EXL advanced its standing from a Major Contributor in the 2025 report to a Leader and Star Performer in 2026.

“EXL has emerged as a Leader and Star Performer in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment 2026 – Americas, supported by strong growth in its overall and digital CXM business, deeper penetration across healthcare, e-commerce, retail and distribution and increasing traction for transformation-led engagements,” said Chhandak Biswas, vice president, Everest Group. “Its EXL Customer Experience Suite, including CX proprietary IP, strengthens its ability to combine interaction intelligence, journey redesign, conversational AI and observability with broader CX advisory and implementation capabilities. Its strong buyer recognition for execution and CX transformation, further supports its move from a Major Contender to a Leader.”

The report cited EXL’s ability to deliver strong client outcomes through customer experience transformation, strategic partnerships, and flexible execution models. The report also highlighted EXL’s investments in AI-enabled CX capabilities, analytics, automation, and proprietary technologies that help organizations improve customer experiences, enhance operational performance, and achieve measurable business results.

“We’re proud to earn this Leader and Star Performer designation and, in the process, help our clients meet their new challenges and deliver better CX, said Shashank Verma, senior vice president and global head of customer service transformation at EXL. “Customer experience is shifting from standalone AI tools to human-integrated AI and agentic workflow, with a greater emphasis on governance and measurable outcomes.”

Read the Everest Group 2026 report and learn how EXL is helping organizations navigate the next generation of customer experience. For more information about EXL’s AI solutions, click here.

About EXL

EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL propels enterprises to go beyond AI ambition to impact by combining the power of data, AI, and deep industry context with trusted execution. Our clients include the world’s leading corporations across insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have over 74,000 employees spanning six continents. For more information, visit http://www.exlservice.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL’s operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management’s experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to maintain and grow client demand, our ability to hire and retain sufficiently trained employees, and our ability to accurately estimate and/or manage costs, rising interest rates, rising inflation and recessionary economic trends, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.

Contact:
Keith Little
Head of Public Relations
media.relations@exlservice.com